Every fall, the same question comes up at kitchen tables across the country: what is changing with Medicare next year? With Medicare 2027 changes, the honest answer comes in two parts. Some of the most important numbers are already set. Other details are not announced yet, and anyone quoting exact figures for them now is guessing. This guide keeps the two groups separate, so you know what you can count on — and what to watch for when the paperwork arrives.
Medicare 2027 changes that are already locked in
Start with prescription drug costs, because this is the change that will matter most to people who take regular medications. Under Part D, there is a yearly cap on what you pay out of pocket for covered drugs: $2,100 in 2026, already set to rise to $2,400 in 2027. Once your spending passes the cap, you pay nothing more for covered Part D drugs for the rest of that year. Medicare calls that stage catastrophic coverage, and for people with expensive prescriptions, it can make a hard year manageable.
Getting to the cap still follows a familiar pattern. First you meet your plan’s deductible. After that, you generally pay 25% coinsurance on covered drugs until your out-of-pocket spending reaches the cap. The exact deductible can vary by plan, and the 2027 amounts are part of what gets confirmed in the fall, so check your own plan’s notice rather than relying on a neighbor’s numbers. What is settled is the shape of it: deductible first, then a quarter of the cost, then nothing more once you cross $2,400 in 2027.
- 2026 cap: $2,100 in out-of-pocket spending on covered Part D drugs.
- 2027 cap: $2,400, already set — after that point, covered drugs cost you $0 for the rest of the year.
- Before the cap: you meet a deductible first, then pay 25% coinsurance.
One more settled piece matters if high drug costs early in the year squeeze your budget. The Medicare Prescription Payment Plan lets members spread their out-of-pocket drug costs across the calendar year instead of facing large bills at the pharmacy counter in the first few months. It does not lower what you owe in total, and it is not right for everyone, but it does smooth out the timing. If you take a costly medication, ask your plan how it would work for you before the new year starts.
Also settled: the GLP-1 Bridge has an end date on the calendar
The second locked-in item matters to a smaller group, but for them it matters a lot. The Medicare GLP-1 Bridge is a temporary program that started on July 1, 2026. Under the Bridge, members pay a flat $50 monthly copayment for covered GLP-1 weight-loss drugs, including Foundayo®, Wegovy®, and Zepbound® KwikPen®. That simple copay is real — but the program was never designed to run forever.
Here is the date to circle: Bridge prior authorizations remain valid through December 31, 2027. That makes 2027 the program’s last scheduled year, and what coverage looks like after that has not been settled yet. What you can do is plan ahead. During 2027, talk with your doctor and your plan about what comes next for your treatment, instead of being caught off guard at the end of the year. A conversation held in the spring is far less stressful than one held in late December.
What is still to be announced for 2027
Now for the second group — the details nobody can hand you yet. Each year, CMS announces the coming year’s premiums and deductibles in the fall. That rhythm is normal, not a delay or a problem. It does mean that if you see a specific 2027 premium or deductible figure circulating before that announcement, you should treat it with real skepticism. The careful move is to wait for the official numbers and then compare them against your own plan’s documents.
Your most important mail this season is the Annual Notice of Change, which arrives in September. It lays out how your current plan is changing for the year ahead — costs, coverage, and the details in between. Read it with a pen in hand. Extra benefits are one place where plans differ quietly from year to year, and our plain-language guide to the Medicare flex card explains how one of the most talked-about benefits actually works, including its limits and fine print, so you can judge any change in yours with clear eyes.
The decisions that lock in your 2027 coverage happen during Open Enrollment, which runs from October 15 through December 7, 2026. That is your window to stay, switch, or adjust based on the fall announcements and your September notice. Mark those dates now, while things are calm.
How to get ready while you wait
You can do useful homework now. Make a short list of what you actually use: your regular prescriptions, your doctors, and any equipment or support your health depends on. Mobility is a good example. If getting around the house has become harder, our guide to Medicare-covered power chairs explains how to qualify and what is included, and families weighing wider options may also find our look at Medicare mobility scooters helpful. Having your real needs written down makes the September notice far easier to judge, because you can check it against your life instead of against a sales pitch.
Then keep it simple. When the Annual Notice of Change arrives, compare it line by line with this year’s coverage. When CMS announces premiums and deductibles in the fall, note only the figures that apply to you, from official sources. During Open Enrollment, make your decision once, carefully, rather than revisiting it with every advertisement. And if you are on the GLP-1 Bridge, put a reminder on the calendar for early 2027 to start the what-comes-next conversation.
The bottom line
Medicare 2027 is partly written already: a $2,400 Part D out-of-pocket cap, a payment plan that can spread drug costs across the year, and a GLP-1 Bridge scheduled to run through December 31, 2027 — and no further. The rest — premiums, deductibles, and your own plan’s final shape — arrives this fall, in official announcements and in one important September envelope. Knowing which group a claim belongs to will save you worry now and help you act quickly when it counts.
